159 related articles for article (PubMed ID: 16637784)
1. Evaluating and treating cardiometabolic risk factors: a case discussion.
Haines ST; Fuke DC; Lender D; Rodgers PT; Sysko SK
Pharmacotherapy; 2006 May; 26(5 Pt 2):32S-41S. PubMed ID: 16637784
[TBL] [Abstract][Full Text] [Related]
2. New and emerging strategies for reducing cardiometabolic risk factors.
Rodgers PT; Fuke DC
Pharmacotherapy; 2006 May; 26(5 Pt 2):13S-31S; quiz 43S-45S. PubMed ID: 16637783
[TBL] [Abstract][Full Text] [Related]
3. [Secondary prevention of coronary heart disease. How effective are modern therapy methods?].
Kolenda KD
Dtsch Med Wochenschr; 2003 Sep; 128(36):1849-53. PubMed ID: 12964107
[No Abstract] [Full Text] [Related]
4. Optimal medical management of peripheral arterial disease.
Rice TW; Lumsden AB
Vasc Endovascular Surg; 2006; 40(4):312-27. PubMed ID: 16959725
[TBL] [Abstract][Full Text] [Related]
5. Is it time to stop treating dyslipidaemia with fibrates?
Benatar JR; Stewart RA
N Z Med J; 2007 Sep; 120(1261):U2706. PubMed ID: 17853928
[TBL] [Abstract][Full Text] [Related]
6. [Conservative treatment of coronary heart disease--current options].
Desch S; Schuler G; Niebauer J
MMW Fortschr Med; 2005 Feb; 147(8):45-7. PubMed ID: 18437860
[TBL] [Abstract][Full Text] [Related]
7. Comparison of secondary prevention of heart disease in Europe: lifestyle getting worse, therapy getting better in Ireland.
Hall M; McGettigan M; O'Callaghan P; Graham I; Shelley E; Feely J
Ir Med J; 2002 Oct; 95(9):272-4. PubMed ID: 12469998
[TBL] [Abstract][Full Text] [Related]
8. Secondary prevention of ischaemic cardiac events.
Gami A
Clin Evid; 2006 Jun; (15):195-228. PubMed ID: 16973010
[No Abstract] [Full Text] [Related]
9. Preventive maintenance of the aging heart.
Miller M; Gottlieb SO
Geriatrics; 1991 Jul; 46(7):22-30. PubMed ID: 2060800
[TBL] [Abstract][Full Text] [Related]
10. Solvay addresses unmet needs in the management of hypertensive patients with cardiometabolic and lipid disorders.
Cardiovasc J Afr; 2009; 20(1):73-4. PubMed ID: 19287821
[No Abstract] [Full Text] [Related]
11. Benefits of risk factor modification through cardiac rehabilitation.
Borrás IC; Cruz-Jiménez M; Nadal E; Middelhoff A; Rivera A
Bol Asoc Med P R; 2008; 100(4):75-9. PubMed ID: 19400532
[TBL] [Abstract][Full Text] [Related]
12. [Cardiometabolic high risk patients with abdominal obesity. Frequency and risk factor profile in primary care].
Scholze J; Lilienthal W; Bramlage P
MMW Fortschr Med; 2007 Sep; 149 Suppl 3():103-10. PubMed ID: 17955787
[TBL] [Abstract][Full Text] [Related]
13. The relationship among risk factor clustering, abdominal obesity, and residual risk for cardiovascular events.
Ryan DH
Rev Cardiovasc Med; 2007; 8(1):9-16. PubMed ID: 17401297
[TBL] [Abstract][Full Text] [Related]
14. Prevention of cardiovascular events in diabetes.
Sigal R; Malcolm J; Meggison H
Clin Evid; 2004 Jun; (11):777-806. PubMed ID: 15652037
[No Abstract] [Full Text] [Related]
15. Elderly patients undergoing major vascular surgery: risk factors and medication associated with risk reduction.
Feringa HH; Bax JJ; Karagiannis SE; Noordzij P; van Domburg R; Klein J; Poldermans D
Arch Gerontol Geriatr; 2009; 48(1):116-20. PubMed ID: 18177954
[TBL] [Abstract][Full Text] [Related]
16. Lipid screening and cardiovascular health in childhood.
Daniels SR; Greer FR;
Pediatrics; 2008 Jul; 122(1):198-208. PubMed ID: 18596007
[TBL] [Abstract][Full Text] [Related]
17. AHA/ACC guidelines for secondary prevention for patients with coronary and other atherosclerotic vascular disease: 2006 update endorsed by the National Heart, Lung, and Blood Institute.
; ; ; Smith SC; Allen J; Blair SN; Bonow RO; Brass LM; Fonarow GC; Grundy SM; Hiratzka L; Jones D; Krumholz HM; Mosca L; Pearson T; Pfeffer MA; Taubert KA
J Am Coll Cardiol; 2006 May; 47(10):2130-9. PubMed ID: 16697342
[No Abstract] [Full Text] [Related]
18. [Arterial hypertension - the specific case].
Weisser B; Düsing R; Mengden T
Dtsch Med Wochenschr; 2001 Nov; 126(44):1235. PubMed ID: 11687982
[No Abstract] [Full Text] [Related]
19. K/DOQI clinical practice guidelines for management of dyslipidemias in patients with kidney disease.
Kidney Disease Outcomes Quality Initiative (K/DOQI) Group
Am J Kidney Dis; 2003 Apr; 41(4 Suppl 3):I-IV, S1-91. PubMed ID: 12671933
[No Abstract] [Full Text] [Related]
20. Treatment and secondary prevention of ischemic coronary events in Croatia (TASPIC-CRO study).
Reiner Z; Mihatov S; Milicić D; Bergovec M; Planinc D;
Eur J Cardiovasc Prev Rehabil; 2006 Aug; 13(4):646-54. PubMed ID: 16874158
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
